We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Novel Method Detects Bacterial Infection in Preterm Infants

By LabMedica International staff writers
Posted on 12 Apr 2016
Print article
Image: The cobas 8000 modular analyzer system (Photo courtesy of Roche Diagnostics).
Image: The cobas 8000 modular analyzer system (Photo courtesy of Roche Diagnostics).
A new criterion has been proposed for diagnosis of bacterial infection in preterm infants and using this method could lead to early diagnosis and treatment for bacterial infection and improve the prognosis for preterm infants.

Infants born prematurely do not have fully developed immune functions and compared to full-term infants, and if preterm infants suffer a bacterial infection there is a higher chance of fatality or negative impact on future growth and development.

Scientists at Kobe University (Japan) examined 1,267 serums from 283 newborns at the neonatal intensive care unit in Kobe University Hospital between June and December 2014. The enrolled newborns were divided into three infant groups as follows: 37 preterm of less than 34 weeks’ gestational age (GA); 61 late preterm of 34 to 36 weeks’ GA, and 185 term infants equal to or greater than 37 weeks’ GA.

Serum procalcitonin (PCT), was used as a marker used for early detection of bacterial infection in adults and children. Serum PCT measurement was performed using 30 μL of serum, the serum PCT concentration was measured by electrochemical luminescence immunoassay using the COBAS 8000e analyzer (Roche Diagnostics, Basel, Switzerland). The results demonstrated that PCT levels in full-term infants rose temporarily one day after birth, returning to the normal level for adults within five days (0.1ng/mL). However, for preterm infants it took nine days after birth for PCT to return to normal levels. Based on these results, the group plotted two reference curves: 50th percentile and 90th percentile values. When they superimposed three cases of preterm infants with bacterial infection on these curves, it clearly showed that in all three cases the serum PCT concentrations were higher than the 95th percentile values.

The authors concluded that that the physiological feature in preterm infants was significantly different from that in late preterm infants, even in those less than 37 weeks’ gestational age. To detect late-onset bacterial infection and sepsis, an age-specific percentile-based reference curve may be useful in preterm infants. Ichiro Morioka, MD, a professor of pediatrics and senior author of the study said, “We could also potentially use this method to limit unnecessary use of antibacterial agents. Our next step is to verify the precision of diagnoses based on these reference curves.” The study was published on April 1, 2016, in the journal Scientific Reports.

Related Links:

Kobe University 
Roche Diagnostics


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Vaginitis Test
Allplex Vaginitis Screening Assay
New
Centromere B Assay
Centromere B Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.